Genomic Surveillance

Genomic surveillance is the systematic sequencing and comparison of viral genomes collected from infected people over time and across locations. It detects mutations, groups related genomes into lineages or variants, and tracks whether genetically changed viruses are spreading differently from other circulating viruses.

From samples to genome sequences

Surveillance begins with representative clinical samples whose viral genetic material is extracted and sequenced. Quality control removes incomplete, contaminated or unreliable data before comparison.

• Each sequence is aligned with a reference genome to identify nucleotide substitutions, insertions and deletions.
• Related mutation patterns are used to assign samples to lineages and construct phylogenetic relationships.
• Sampling across places, population groups and time periods helps distinguish persistent trends from isolated detections.

How significant changes are recognised

A mutation becomes epidemiologically important not merely because it is new, but because several kinds of evidence indicate that it may alter viral behaviour.

• A lineage whose share rises consistently may possess a growth or transmission advantage, although sampling patterns and outbreaks must also be considered.
• Clusters appearing in several locations can indicate wider spread rather than a single local transmission chain.
• Changes in genes coding for functionally important viral proteins are prioritised for laboratory assessment of infectivity, immune escape or diagnostic performance.
• Genomic findings are linked with clinical and epidemiological data to examine associations with disease severity, reinfection, vaccine breakthrough or unusual outbreaks.

Interpretation and public health use

Genomic surveillance provides an early warning and guides risk assessment, diagnostic review, vaccine research and outbreak investigation. However, a genome sequence alone cannot prove that a mutation changes transmissibility or severity.

• Reliable conclusions require adequate and representative sampling, timely sequencing and standardised metadata.
• Observed genetic change must be validated through epidemiological analysis, laboratory studies and continued monitoring.